These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Rivaroxaban vs. warfarin on extended deep venous thromboembolism treatment: A cost analysis. Diken AI; Yalçınkaya A; Hanedan MO; Erol ME; Ercen Diken Ö Phlebology; 2018 Feb; 33(1):53-59. PubMed ID: 28056701 [TBL] [Abstract][Full Text] [Related]
3. [Patient with antithrombotic medication. Which do bleedings or preoperative?]. Stiefelhagen P Laryngorhinootologie; 2006 Jan; 85(1):50-60; quiz 61-5. PubMed ID: 16444657 [TBL] [Abstract][Full Text] [Related]
4. The use of oral anticoagulants (warfarin) in older people. AGS Clinical Practices Committee. American Geriatric Society. J Am Geriatr Soc; 2000 Feb; 48(2):224-7. PubMed ID: 10682955 [No Abstract] [Full Text] [Related]
5. Warfarin: better the devil you know. Blockman M Cardiovasc J Afr; 2017; 28(6):344-345. PubMed ID: 29297543 [No Abstract] [Full Text] [Related]
6. [What, when, for how long and why?]. Stiefelhagen P MMW Fortschr Med; 2013 Jan; 155(1):24. PubMed ID: 23573712 [No Abstract] [Full Text] [Related]
7. [Anticoagulation in the elderly--a thin line between benefit and risk]. Steffel J; Lüscher TF MMW Fortschr Med; 2009 Apr; 151(16):33-6. PubMed ID: 19658293 [No Abstract] [Full Text] [Related]
8. Sulodexide for the extended treatment of venous thromboembolism. Walenga JM; Fareed J; Ramacciotti E Int Angiol; 2016 Dec; 35(6):531-533. PubMed ID: 27680735 [No Abstract] [Full Text] [Related]
9. [Management of long-term anticoagulation. Narrow margin between effectiveness and risk]. Stiefelhagen P MMW Fortschr Med; 2004 Sep; 146(39):I-X; quiz XI-XII. PubMed ID: 15532419 [No Abstract] [Full Text] [Related]
10. Updated guidelines on outpatient anticoagulation. Wigle P; Hein B; Bloomfield HE; Tubb M; Doherty M Am Fam Physician; 2013 Apr; 87(8):556-66. PubMed ID: 23668445 [TBL] [Abstract][Full Text] [Related]
14. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study. Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852 [TBL] [Abstract][Full Text] [Related]
15. [Procedures on patients receiving NOACs : What's possible?]. Polzin A; Kelm M; Horn P Med Klin Intensivmed Notfmed; 2017 Mar; 112(2):117-124. PubMed ID: 28074294 [TBL] [Abstract][Full Text] [Related]
16. [Monitoring of anticoagulation--management in practice]. Schinzel H; Weilemann LS Dtsch Med Wochenschr; 2014 Jan; 139 Suppl 1():S27-30. PubMed ID: 24446039 [No Abstract] [Full Text] [Related]
19. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial. Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA; Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716 [TBL] [Abstract][Full Text] [Related]
20. [Use of warfarin and low range INR in the prevention of recurrent venous thrombosis]. Quintero J; Torres E; Diez-Ewald M; Arteaga-Vizcaíno M; Vizcaíno G; León M; Rodríguez Z; Fernández N Invest Clin; 2011 Sep; 52(3):230-8. PubMed ID: 21950194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]